Article
11 Dec 2025
California Advances Corporate Climate Disclosure Requirements: What Companies Doing Business In California Need To Know
CONTRIBUTING SINCE MARCH 2011
Buchanan Ingersoll & Rooney PC
With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
POPULAR TOPICS
Food, Drugs, Healthcare, Life Sciences
Cannabis & Hemp
International Law
Corporate/Commercial Law
Technology
Buchanan Ingersoll & Rooney PC are most popular:
- within Finance and Banking, Media, Telecoms, IT, Entertainment and Accounting and Audit topic(s)
DETAILS
United States
+1 412 562 8800
Union Trust Building
501 Grant Street
Suite 200
Pittsburgh
United States
Contact Firm
COMPANY CONTENT
Article
09 Dec 2025
Privacy And Data Security Enforcement: Where Regulators Struck Hardest In 2025
Article
05 Dec 2025
United States Government Steps Up Prosecutions Of Illegal Export Of Supercomputing Technologies
Article
04 Dec 2025
Disclaimer During Later Patent Prosecution Can Limit Earlier, Issued Family Members
Article
02 Dec 2025
Recent Updates Transforming Plan Sponsor Relationships With Pharmacy Benefit Managers
Article
02 Dec 2025
Special Considerations For Assigning A Continuation-In-Part Patent Application
Article
01 Dec 2025
State PBM Oversight Has Been Growing But Enforcement Still Falls Short: Why Pharmacies Must Step Up
Article
01 Dec 2025
Bridging The Gap: Maine's New Law Empowers Pharmacies And Pharmacists To Improve Rural Access To Medications
Article
01 Dec 2025
The Future Of College Sports In Flux: Big Ten's Private Equity Deal Sparks Uncertainty
Article
01 Dec 2025
Kentucky Pharmacies: Prepare For USP Changes In The New Year
Article
28 Nov 2025
Alternative Power Plays: Transitions To Transmissions (Podcast)
Article
27 Nov 2025
EEOC Issues Directive To Close All Pending Charges Alleging Only Disparate Impact In The Wake Of Trump's April 23 Executive Order
Article
27 Nov 2025
Increased Federal Enforcement Of Illicit Ends Products
Article
26 Nov 2025
Division Of Corporate Finance Announcement On Rule 14a-8
Article
26 Nov 2025
Employees Are Entitled To Reasonable, Not Preferred, Accommodation
Article
25 Nov 2025
The Department Of Justice Deploys Health Care Fraud Unit Strike Force To The Country's Premier Healthcare Fraud Enforcement United States Attorney's Office
Article
20 Nov 2025
Hemp Industry Changes In Federal Legislation
Article
19 Nov 2025
Cigna's Rebate-Free Model: What It Really Means For Plan Sponsors, Pharmacies And The Industry
Article
17 Nov 2025
Eleventh Circuit Refuses To Enforce Arbitration Of TCPA And FTSA Claims
Article
17 Nov 2025
California Leads Regulatory Frontier With New Privacy And Artificial Intelligence Laws For 2026
AWARDS
